Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research

REFERENCES

• Center for Disease Control and Prevention. Increases in Heroin Overdose Deaths—28 States, 2010 to 2012. 2014; 63:849–54.
   Google Scholar
• Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008; 8:CD004145.
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3:CD002209.
   PubMed Web of Science ®Google Scholar
• Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcomes. New York: Springer-Verlag, 1991.
   Google Scholar
• Schwartz RP, Kelly SM, O'Grady KE, Gandhi D, Jaffe JH. Interim methadone treatment compared to standard methadone treatment: 4-month findings. J Subst Abuse Treat 2011; 41:21–9.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9:199–213.
   PubMed Web of Science ®Google Scholar
• Boatler JF, Knight K, Simpson DD. Assessment of an AIDS intervention program during drug abuse treatment. J Subst Abuse Treat 1994; 11:367–72.
   PubMed Web of Science ®Google Scholar
• Camacho LM, Brown BS, Simpson DD. Psychological dysfunction and HIV/AIDS risk behavior. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:198–202.
   PubMedGoogle Scholar
• National Association of State Alcohol and Drug Abuse Directors Inc. Issue brief: methadone maintenance treatment and the criminal justice system. Washington, DC: NASADAD, 2006.
   Google Scholar
• Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 2009; 105:83–8.
   PubMed Web of Science ®Google Scholar
• Mitchell SG, Kelly SM, Brown BS, O'Grady KE, Schwartz RP. HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults. Am J Drug Alcohol Abuse 2012; 38:328–33.
   PubMed Web of Science ®Google Scholar
• Peterson JA, Schwartz RP, Mitchell SG, et al. Why don't out-of-treatment individuals enter methadone treatment programs? Int J Drug Policy 2010; 21:36–42.
   PubMed Web of Science ®Google Scholar
• Mitchell SG, Kelly SM, Brown BS, et al. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users. J Psychoactive Drugs 2009; 41:145–52.
   PubMed Web of Science ®Google Scholar
• Lewis DC. Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment. J Addict Dis 1999; 18:5–21.
   PubMed Web of Science ®Google Scholar
• Wenger LD, Rosenbaum M. Drug treatment on demand—not. J Psychoactive Drugs 1994; 26:1–11.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (IOM). Federal Regulation of Methadone Treatment. In: Retting RA, Yarmolinsky A, eds. Washington, DC: National Academy Press, 1995.
   Google Scholar
• McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269:1953–9.
   PubMed Web of Science ®Google Scholar
• Yancovitz SR, Des Jarlais DC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991; 81:1185–91.
   PubMed Web of Science ®Google Scholar
• Federal Register. Title 21, 1993. Codified at 58 CFR §495, pt 291. USA, 1993.
   Google Scholar
• Schwartz RP, Highfield DA, Jaffe JH, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006; 63:102–9.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Jaffe JH, O'Grady K, Das B, Highfield DA, Wilson ME. Scaling-up interim methadone maintenance: treatment for 1,000 heroin addicts. J Subst Abuse Treatment 2009; 37:362–7.
   PubMed Web of Science ®Google Scholar
• Wilson ME, Schwartz RP, O'Grady KE, Jaffe JH. Impact of interim methadone maintenance on HIV risk behaviors. J Urban Health 2010; 87:586–91.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Jaffe JH, O'Grady KE, et al. Interim methadone treatment: impact on arrests. Drug Alcohol Depend 2009; 103:148–54.
   PubMed Web of Science ®Google Scholar
• Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008; 103:462–8.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003; 25:125–34.
   PubMed Web of Science ®Google Scholar
• Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993; 6:1049–56.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98:673–84.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:261–78.
   Web of Science ®Google Scholar
• Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H. Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Addiction 2014; 109:20–32.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Marsden ME, Rachal JV, Harwood HI, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. Chapel Hill, NC: University of North Carolina Press, 1989.
   Google Scholar
• Magura S, Nwakeze PC, Kang SY, Demsky S. Program quality effects on patient outcomes during methadone maintenance: a study of 17 clinics. Subst Use Misuse 1999; 34:1299–324.
   PubMed Web of Science ®Google Scholar
• Reisinger HS, Schwartz RP, Mitchell SG, et al. Premature discharge from methadone treatment: patient perspectives. J Psychoactive Drugs 2009; 41:285–96.
   PubMed Web of Science ®Google Scholar
• Gryczynski J, Schwartz R, O'Grady K, Jaffe J. Dropout from interim methadone and subsequent comprehensive methadone maintenance. Am J Drug Alcohol Abuse 2009; 35:394–8.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat 2003; 24:305–11.
   PubMed Web of Science ®Google Scholar
• Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993; 30:357–67.
   Web of Science ®Google Scholar
• Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 1997; 47:227–35.
   PubMed Web of Science ®Google Scholar
• Kelly SM, Schwartz RP, O'Grady KE, Gandhi D, Jaffe JH. Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial. J Addict Med 2012; 6:145–52.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Alexandre PK, Kelly SM, O'Grady KE, Gryczynski J, Jaffe JH. Interim versus standard methadone treatment: a benefit-cost analysis. J Subst Abuse Treat 2014; 46:306–14.
   PubMed Web of Science ®Google Scholar
• Novick DM, Joseph H. Medical maintenance: the treatment of chronic opiate dependence in general medical practice. J Subst Abuse Treat 1991; 8:233–9.
   PubMed Web of Science ®Google Scholar
• Novick DM, Joseph H, Salsitz EA, et al. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years. J Gen Intern Med 1994; 9:127–30.
   PubMed Web of Science ®Google Scholar
• Novick DM, Pascarelli EF, Joseph H, et al. Methadone maintenance patients in general medical practice. A preliminary report. JAMA 1988; 259:3299–302.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. Am J Addict 1999; 8:293–9.
   PubMed Web of Science ®Google Scholar
• Federal Register. Substance Abuse Mental Health Services Administration 21 CRF Part 291, Vol. 6, 2001:4091.
   Google Scholar
• Mitchell SG, Kelly SM, Gryczynski J, et al. African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients. Drug Alcohol Depend 2012; 122:55–60.
   PubMed Web of Science ®Google Scholar
• Mitchell SG, Gryczynski J, Schwartz RP, O'Grady KE, Olsen YK, Jaffe JH. A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug Alcohol Depend 2013; 128:222–9.
   PubMed Web of Science ®Google Scholar
• Woody GE, Munoz A. Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment. Curr Psychiatry Rep 2000; 2:505–7.
   PubMedGoogle Scholar
• Schwartz RP, Gryczynski J, O'Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health 2013; 103:917–22.
   PubMed Web of Science ®Google Scholar
• Auriacombe M, Fatseas M, Dubernet J, Daulouede JP, Tignol J. French field experience with buprenorphine. Am J Addict 2004; 13(1):S17–28.
   PubMed Web of Science ®Google Scholar
• Senay EC, Jaffe JH, diMenza S, Renault PF. A 48-week study of methadone, methadyl acetate, and minimal services. In: Fisher S, Freeman A, eds. Opiate dependence: origins and treatment. New York: Halstead Press, 1973:185–201.
   Google Scholar
• Calsyn DA, Wells EA, Saxon AJ, et al. Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome. J Addict Dis 1994; 13:47–63.
   PubMed Web of Science ®Google Scholar
• Gruber VA, Delucchi KL, Kielstein A, Batki SL. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend 2008; 94:199–206.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Gandotra N, Kolodner K, Brooner RK. Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes. Drug Alcohol Depend 2012; 124:162–6.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King VL, Neufeld K, Peirce J, Kolodner K, Brooner RK. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction 2009; 104:786–95.
   Google Scholar
• Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend 2006; 83:225–32.
   PubMed Web of Science ®Google Scholar
• Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat 2000; 19:247–52.
   PubMed Web of Science ®Google Scholar
• Magura S, Lee JD, Hershberger J, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend 2009; 99:222–30.
   PubMed Web of Science ®Google Scholar
• Zanis DA, Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52:257–60.
   PubMed Web of Science ®Google Scholar
• Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006; 355:365–74.
   PubMed Web of Science ®Google Scholar
• Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011; 68:1238–46.
   PubMed Web of Science ®Google Scholar
• Avants SK, Margolin A, Sindelar JL, et al. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am J Psychiatry 1999; 156:27–33.
   PubMed Web of Science ®Google Scholar